SCHEMBL181410

SCHEMBL181410

O=C(N[C@@H](Cc1ccc(-n2c(=O)[nH]c3ccc(I)cc3c2=O)cc1)C(=O)O)c1c(Cl)cccc1Cl

nearest known ligand 0.55

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 19/20 0.55
ITGB7 P26010 16/20 0.55
ITGB1 P05556 16/20 0.55
ALB P02768 1/20 0.48
IL2 P60568 1/20 0.48
ITGA2 P17301 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4808821 1.00 ITGA4 (0.55) ITGA4ITGB7ITGB1ALBIL2
SCHEMBL24336796 0.90 ITGA4 (0.55) ITGA4ITGB7ITGB1ITGA2
SCHEMBL4325518 0.85 ITGA4 (0.56) ITGA4ITGB7ITGB1ITGA2
SCHEMBL181131 0.82 ITGA4 (0.79) ITGA4ITGB7ITGB1
SCHEMBL4818034 0.82 ITGA4 (0.79) ITGA4ITGB7ITGB1
SCHEMBL4814330 0.82 ITGA4 (0.53) ITGA4ITGB7ITGB1
SCHEMBL17117090 0.81 ITGA4 (0.47) ITGA4ITGB7ITGB1
SCHEMBL12123745 0.79 ITGA4 (0.61) ITGA4ITGB7ITGB1
SCHEMBL13239498 0.79 ITGA4 (0.62) ITGA4ITGB7ITGB1ITGA2
SCHEMBL4818281 0.79 ITGA4 (0.53) ITGA4ITGB7ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1700850-B1 Phenylalanine derivative AJINOMOTO KK (JP) 2015-07-15 EP disclosed
EP-2803667-A1 Phenylalanine derivatives AJINOMOTO CO., INC. (JP) 2014-11-19 EP disclosed
EP-2615087-A2 Phenylalanine derivatives AJINOMOTO CO., INC. (JP) 2013-07-17 EP disclosed
EP-1916241-B1 CRYSTAL OF PHENYLALANINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF AJINOMOTO KK (JP) 2013-06-12 EP disclosed
US-8309561-B2 N-(2,6-dichlorobenzoyl)-4-[1-methyl-7-(pyrrolidine-1-ylmethyl)-2,4-quinazoline-dione-3-yl]-L-phenylalanine trifluoroacetate; 4 integrin antagonist; antiinflammatory, anticarcinogenic agent, antiallergent; asthma, psoriasis, cardiovascular diseases, arterial sclerosis, restenosis, tumor proliferation AJINOMOTO CO., INC. (JP) 2012-11-13 US disclosed
US-8268844-B2 Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-l-phenylalanine hydrochloride, production method thereof and use thereof AJINOMOTO CO., INC. (JP) 2012-09-18 US disclosed
EP-2402326-A1 Crystals of hydrochloride salts of a Phenylalanine Derivative, Production Method Thereof and Use Thereof as alpha4 integrin Inhibitors Ajinomoto Co., Inc. (JP) 2012-01-04 EP disclosed
US-20110009434-A1 CRYSTALS OF ISOPROPYL ESTER OF N-(2,6-DICHLOROBENZOYL)-4-[6-(METHYLAMINO)METHYL -1-METHYL-2,4-DIOXO-1,4-DIHYDROQUINAZOLINE-3(2H)-YL]-L- PHENYLALANINE HYDROCHLORIDE, PRODUCTION METHOD THEREOF AND USE THEREOF AJINOMOTO CO., INC. (JP) 2011-01-13 US disclosed
US-7842700-B2 Crystals of isopropyl ester of N-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl-1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2H)-yl]-L-phenylalanine hydrochloride, production method thereof and use thereof AJINOMOTO CO., INC. (JP) 2010-11-30 US disclosed
US-20080108637-A1 CRYSTALS OF PHENYLALANINE DERIVATIVES, PRODUCTION METHOD THEREOF AND USE THEREOF AJINOMOTO CO., INC. (JP) 2008-05-08 US disclosed
US-20080108634-A1 NOVEL PHENYLALANINE DERIVATIVES AJINOMOTO CO., INC. (JP) 2008-05-08 US disclosed
EP-1916241-A1 CRYSTAL OF PHENYLALANINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME AND USE THEREOF Ajinomoto Co., Inc. (JP) 2008-04-30 EP disclosed
US-7345049-B2 Phenylalanine derivatives AJINOMOTO CO., INC. (JP) 2008-03-18 US disclosed
EP-1700850-A1 NOVEL PHENYLALANINE DERIVATIVE Ajinomoto Co., Inc. (JP) 2006-09-13 EP disclosed
US-20050222141-A1 Novel phenylalanine derivatives AJINOMOTO CO., INC. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080108634-A1 NOVEL PHENYLALANINE DERIVATIVES ITGB4, ITGA4, ITGAV ITGA4 2/4885ITGB7 13/4885ITGB1 10/4885
US-20050222141-A1 Novel phenylalanine derivatives ITGB4, ITGA4, ITGAV ITGA4 2/4885ITGB7 13/4885ITGB1 10/4885
US-20110009434-A1 CRYSTALS OF ISOPROPYL ESTER OF N-(2,6-DICHLOROBENZOYL)-4-[6-(METHYLAMINO)METHYL -1-METHYL-2,4-DIOXO-1,4-DIHYDROQUINAZOLINE-3(2H)-YL]-L- PHENYLALANINE HYDROCHLORIDE, PRODUCTION METHOD THEREOF AND USE THEREOF ITGB4, ITGA4, ITGAL ITGA4 2/4885ITGB7 14/4885ITGB1 8/4885
US-20080108637-A1 CRYSTALS OF PHENYLALANINE DERIVATIVES, PRODUCTION METHOD THEREOF AND USE THEREOF PAH, TYR, PEPD ITGA4 4848/4885ITGB7 4712/4885ITGB1 4869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.